Table 1.
Participant Demographics
Participant Characteristic | Total sample n= 40 |
Brain n= 10 |
Breast n= 10 |
Colorectal n= 10 | Lung n= 10 |
---|---|---|---|---|---|
Current age, mean (range) | 54.8 (26-83) |
47.1 (26-67) |
53.2 (37-67) |
54.2 (33-66) |
64.6 (41-83) |
Years since first diagnosed with cancer, mean (range) | 5.9 (0-24) | 2.2 (0-5) | 9.3 (1-24) | 4.3 (2-9) | 7.8 (0-24) |
n (%) | |||||
Sex (female) | 27 (68) | 4 (40) | 10 (100) | 5 (50) | 8 (80) |
Marital Status | |||||
Single | 6 (15) | 2 (20) | 2 (20) | 0 (0) | 2 (20) |
Divorced | 3 (7) | 0 (0) | 2 (20) | 1 (10) | 0 (0) |
Married | 29 (73) | 8 (80) | 6 (60) | 8 (80) | 7 (70) |
Widowed | 2 (5) | 0 (0) | 0 (0) | 1 (10) | 1 (10) |
Race | |||||
African American or Black | 6 (15) | 1 (10) | 4 (40) | 0 (0) | 1 (10) |
Asian | 1 (3) | 0 (0) | 0 (0) | 0 (0) | 1 (10) |
White | 33 (82) | 9 (90) | 6 (60) | 10 (100) | 8 (80) |
Receiving treatment at time of interview | 28 (70) | 8 (80) | 9 (90) | 4 (40) | 7 (70) |
Disease Stage (total n=30) | |||||
I | 2 (6) | N/A | 1 (10) | 0 (0) | 1 (10) |
II | 6 (20) | 2 (20) | 3 (30) | 1 (10) | |
III | 5 (17) | 2 (20) | 2 (20) | 1 (10) | |
IV | 17 (57) | 5 (50) | 5 (50) | 7 (70) | |
Treatment history, | |||||
Chemotherapy | 35 (88) | 10 (100) | 9 (90) | 7 (70) | 9 (90) |
Surgery | 26 (65) | 10 (100) | 8 (80) | 2 (20) | 6 (60) |
Radiation | 21 (53) | 6 (60) | 6 (60) | 7 (70) | 2 (20) |
Hormone therapy | 6 (15) | 0 (0) | 6 (60) | 0 (0) | 0 (0) |
Immunotherapy | 10 (25) | 4 (40) | 1 (10) | 1 (10) | 4 (40) |
Abbreviation: N/A: not applicable.